Waiting List and Kidney Transplant Vascular Risk: An Ongoing Unmet Concern
Open Access
- 4 December 2019
- journal article
- review article
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 45 (1), 1-27
- https://doi.org/10.1159/000504546
Abstract
Background: Chronic kidney disease (CKD) is an important independent risk factor for adverse cardiovascular events in patients waitlisted for kidney transplantation (KT). Although KT reduces cardiovascular risk, these patients still have a higher all-cause and cardiovascular mortality than the general population. This concerning situation is due to a high burden of traditional and nontraditional risk factors as well as uremia-related factors and transplant-specific factors, leading to 2 differentiated processes under the framework of CKD, atherosclerosis and arteriosclerosis. These can be initiated by insults to the vascular endothelial endothelium, leading to vascular calcification (VC) of the tunica media or the tunica intima, which may coexist. Several pathogenic mechanisms such as inflammation-related endothelial dysfunction, mineral metabolism disorders, activation of the renin-angiotensin system, reduction of nitric oxide, lipid disorders, and the fibroblast growth factor 23-klotho axis are involved in the pathogenesis of atherosclerosis and arteriosclerosis, including VC. Summary: This review focuses on the current understanding of atherosclerosis and arteriosclerosis, both in patients on the waiting list as well as in kidney transplant recipients, emphasizing the cardiovascular risk factors in both populations and the inflammation-related pathogenic mechanisms. Key Message: The importance of cardiovascular risk factors and the pathogenic mechanisms related to inflammation in patients waitlisted for KT and kidney transplant recipients.Keywords
This publication has 222 references indexed in Scilit:
- A Two-Year Randomized Trial of Obesity Treatment in Primary Care PracticeThe New England Journal of Medicine, 2011
- Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease: A Systematic Review and Meta-AnalysisJournal of the American College of Cardiology, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and ControversiesAmerican Journal of Kidney Diseases, 2010
- Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudyAmerican Journal of Kidney Diseases, 2009
- Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery diseaseKidney International, 2009
- Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart StudyAmerican Journal of Kidney Diseases, 2008
- siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migrationAtherosclerosis, 2008
- Chronic Kidney Disease Associated Mortality in Diastolic Versus Systolic Heart Failure: A Propensity Matched StudyThe American Journal of Cardiology, 2007
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995